Minute dosages of α(ν)β(3)-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits

Fumagillin suppresses angiogenesis in cancer models and clinical trials, but it is associated with neurotoxicity at systemic doses. In this study, α(ν)β(3)-targeted fumagillin nanoparticles were used to suppress the neovasculature and inhibit Vx-2 adenocarcinoma development using minute drug doses....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Winter, Patrick M., Schmieder, Anne H., Caruthers, Shelton D., Keene, Jeffery L., Zhang, Huiying, Wickline, Samuel A., Lanza, Gregory M.
Format: Artigo
Langue:Inglês
Publié: The Federation of American Societies for Experimental Biology 2008
Sujets:
Research Communications
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2493462/
https://ncbi.nlm.nih.gov/pubmed/18362202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.07-103929
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires